G. R. Burmester

发表论文 9 篇 · 总被引 3 次 · h-index 1

代表论文

ABS0335 PHARMACOKINETIC, PHARMACODYNAMIC, SAFETY AND IMMUNOGENICITY EVALUATION OF THE PROPOSED TOCILIZUMAB BIOSIMILAR RGB-19 SUBCUTANEOUSLY ADMINISTERED TO HEALTHY MALE PARTICIPANTS: A PHASE 1, RANDOMISED, SINGLE-DOSE CROSS-OVER STUDY (2025 · Annals of the Rheumatic Diseases · 被引 2)
ABS0504 REAL WORLD EVALUATION ON THE EFFECTIVENESS OF BARICITINIB OR OTHER TREATMENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE EUROPEAN AND NON-EUROPEAN COHORTS OF THE RA-BE-REAL STUDY (2025 · Annals of the Rheumatic Diseases)
POS0590 CHARACTERIZATION OF IMPROVEMENTS IN PAIN, HAQ-DI AND RADIOGRAPHIC AND LONG-TERM SAFETY OUTCOMES IN DISTINCT CDAI TRAJECTORY GROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH FILGOTINIB: A POST HOC ANALYSIS OF FINCH 1 (2025 · Annals of the Rheumatic Diseases)
Évaluation en situation réelle de l’efficacité du baricitinib ou d’autres traitements chez des patients atteints de polyarthrite rhumatoïde : données issues de cohortes européennes et hors Europe de l’étude RA-BE-REAL (2025 · Revue du Rhumatisme)
POS0659 EFFICACY, SAFETY AND IMMUNOGENICITY OF THE PROPOSED TOCILIZUMAB BIOSIMILAR RGB-19, INTRAVENOUSLY ADMINISTERED TO PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS: WEEK 24 DATA FROM A PHASE 3 STUDY (2025 · Annals of the Rheumatic Diseases)
POS0461 Characterization of patients with rheumatoid arthritis based on distinct patterns of pain improvement following treatment with filgotinib: A post hoc analysis of FINCH 1 (2025 · Annals of the Rheumatic Diseases)